Skip Nav Destination
Issues
1 October 2004
ISSN 0012-1797
EISSN 1939-327X
Perspectives in Diabetes
Neuronal Glucosensing: What Do We Know After 50 Years?
Diabetes October 2004, Vol.53, 2521-2528. doi:https://doi.org/10.2337/diabetes.53.10.2521
Signal Transduction
Intracerebroventricular Neuropeptide Y Infusion Precludes Inhibition of Glucose and VLDL Production by Insulin
Anita M. van den Hoek; Peter J. Voshol; Barbara N. Karnekamp; Ruud M. Buijs; Johannes A. Romijn; Louis M. Havekes; Hanno Pijl
Diabetes October 2004, Vol.53, 2529-2534. doi:https://doi.org/10.2337/diabetes.53.10.2529
Transferrin and Iron Contribute to the Lipolytic Effect of Serum in Isolated Adipocytes
Diabetes October 2004, Vol.53, 2535-2541. doi:https://doi.org/10.2337/diabetes.53.10.2535
Hypothalamic ATP-sensitive K + Channels Play a Key Role in Sensing Hypoglycemia and Triggering Counterregulatory Epinephrine and Glucagon Responses
Mark L. Evans; Rory J. McCrimmon; Daniel E. Flanagan; Tara Keshavarz; Xiaoning Fan; Ewan C. McNay; Ralph J. Jacob; Robert S. Sherwin
Diabetes October 2004, Vol.53, 2542-2551. doi:https://doi.org/10.2337/diabetes.53.10.2542
Obesity Study
Regulation of Growth Hormone Secretagogue Receptor Gene Expression in the Arcuate Nuclei of the Rat by Leptin and Ghrelin
Ruben Nogueiras; Sulay Tovar; Sharon E. Mitchell; D. Vernon Rayner; Zoe A. Archer; Carlos Dieguez; Lynda M. Williams
Diabetes October 2004, Vol.53, 2552-2558. doi:https://doi.org/10.2337/diabetes.53.10.2552
Immunology and Transplantation
Response of Human Islets to Isolation Stress and the Effect of Antioxidant Treatment
Rita Bottino; A.N. Balamurugan; Hubert Tse; C. Thirunavukkarasu; Xinhui Ge; Jennifer Profozich; Martha Milton; Audra Ziegenfuss; Massimo Trucco; Jon D. Piganelli
Diabetes October 2004, Vol.53, 2559-2568. doi:https://doi.org/10.2337/diabetes.53.10.2559
Elevated C-Reactive Protein Levels in the Development of Type 1 Diabetes
H. Peter Chase; Sonia Cooper; Iris Osberg; Lars C. Stene; Katherine Barriga; Jill Norris; George S. Eisenbarth; Marian Rewers
Diabetes October 2004, Vol.53, 2569-2573. doi:https://doi.org/10.2337/diabetes.53.10.2569
A Salen-Manganese Catalytic Free Radical Scavenger Inhibits Type 1 Diabetes and Islet Allograft Rejection
Angelica P. Olcott; Georges Tocco; Jide Tian; Dan Zekzer; Jon Fukuto; Louis Ignarro; Daniel L. Kaufman
Diabetes October 2004, Vol.53, 2574-2580. doi:https://doi.org/10.2337/diabetes.53.10.2574
Investigation of the Role of B-Cells in Type 1 Diabetes in the NOD Mouse
F. Susan Wong; Li Wen; Michelle Tang; Murugappan Ramanathan; Irene Visintin; Joanne Daugherty; Lynn G. Hannum; Charles A. Janeway, Jr; Mark J. Shlomchik
Diabetes October 2004, Vol.53, 2581-2587. doi:https://doi.org/10.2337/diabetes.53.10.2581
Islet Study
Promotion of β-Cell Differentiation by Conophylline in Fetal and Neonatal Rat Pancreas
Takeki Ogata; Lei Li; Satoko Yamada; Yoritsuna Yamamoto; Yuji Tanaka; Izumi Takei; Kazuo Umezawa; Itaru Kojima
Diabetes October 2004, Vol.53, 2596-2602. doi:https://doi.org/10.2337/diabetes.53.10.2596
Artifactual Insulin Release From Differentiated Embryonic Stem Cells
Mattias Hansson; Anna Tonning; Ulrik Frandsen; Andreas Petri; Jayaraj Rajagopal; Mikael C.O. Englund; R. Scott Heller; Joakim Håkansson; Jan Fleckner; Helen Nilsson Sköld; Douglas Melton; Henrik Semb; Palle Serup
Diabetes October 2004, Vol.53, 2603-2609. doi:https://doi.org/10.2337/diabetes.53.10.2603
Evidence Against the Involvement of Oxidative Stress in Fatty Acid Inhibition of Insulin Secretion
Diabetes October 2004, Vol.53, 2610-2616. doi:https://doi.org/10.2337/diabetes.53.10.2610
Pathophysiology
Hepatic Insulin Resistance Precedes the Development of Diabetes in a Model of Intrauterine Growth Retardation
Diabetes October 2004, Vol.53, 2617-2622. doi:https://doi.org/10.2337/diabetes.53.10.2617
Elevations in Markers of Liver Injury and Risk of Type 2 Diabetes: The Insulin Resistance Atherosclerosis Study
Anthony J.G. Hanley; Ken Williams; Andreas Festa; Lynne E. Wagenknecht; Ralph B. D’Agostino, Jr.; Judy Kempf; Bernard Zinman; Steven M. Haffner
Diabetes October 2004, Vol.53, 2623-2632. doi:https://doi.org/10.2337/diabetes.53.10.2623
Alterations in Plasma Vitamin E Distribution in Type 2 Diabetic Patients With Elevated Plasma Phospholipid Transfer Protein Activity
Martina Schneider; Bruno Vergès; Alexis Klein; Elizabeth R. Miller; Valérie Deckert; Catherine Desrumaux; David Masson; Philippe Gambert; Jean-Marcel Brun; Jamila Fruchart-Najib; Denis Blache; Joseph L. Witztum; Laurent Lagrost
Diabetes October 2004, Vol.53, 2633-2639. doi:https://doi.org/10.2337/diabetes.53.10.2633
Complications
Nitric Oxide–Sensitive Soluble Guanylyl Cyclase Activity Is Preserved in Internal Mammary Artery of Type 2 Diabetic Patients
Diabetes October 2004, Vol.53, 2640-2644. doi:https://doi.org/10.2337/diabetes.53.10.2640
Preserved Glucoregulation but Attenuation of the Vascular Actions of Insulin in Mice Heterozygous for Knockout of the Insulin Receptor
Stephen B. Wheatcroft; Ajay M. Shah; Jian-Mei Li; Edward Duncan; Brian T. Noronha; Paul A. Crossey; Mark T. Kearney
Diabetes October 2004, Vol.53, 2645-2652. doi:https://doi.org/10.2337/diabetes.53.10.2645
Glycation Inactivation of the Complement Regulatory Protein CD59: A Possible Role in the Pathogenesis of the Vascular Complications of Human Diabetes
Xuebin Qin; Allison Goldfine; Nicole Krumrei; Luciano Grubissich; Juan Acosta; Michael Chorev; Arthur P. Hays; Jose A. Halperin
Diabetes October 2004, Vol.53, 2653-2661. doi:https://doi.org/10.2337/diabetes.53.10.2653
Thiazolidinediones Reduce Endothelial Expression of Receptors for Advanced Glycation End Products
Nikolaus Marx; Daniel Walcher; Nina Ivanova; Kirstin Rautzenberg; Annelie Jung; Reinhard Friedl; Vinzenz Hombach; Raffaele de Caterina; Giuseppina Basta; Marie-Paule Wautier; Jean-Luc Wautiers
Diabetes October 2004, Vol.53, 2662-2668. doi:https://doi.org/10.2337/diabetes.53.10.2662
Selective Loss of Calcitonin Gene-Related Peptide-Expressing Primary Sensory Neurons of the A-Cell Phenotype in Early Experimental Diabetes
Diabetes October 2004, Vol.53, 2669-2675. doi:https://doi.org/10.2337/diabetes.53.10.2669
Genetics
Genome-wide Scan for Metabolic Syndrome and Related Quantitative Traits in Hong Kong Chinese and Confirmation of a Susceptibility Locus on Chromosome 1q21-q25
Maggie C.Y. Ng; Wing-Yee So; Vincent K.L. Lam; Clive S. Cockram; Graeme I. Bell; Nancy J. Cox; Juliana C.N. Chan
Diabetes October 2004, Vol.53, 2676-2683. doi:https://doi.org/10.2337/diabetes.53.10.2676
Differences in the Contribution of HLA-DR and -DQ Haplotypes to Susceptibility to Adult- and Childhood-Onset Type 1 Diabetes in Japanese Patients
Satoshi Murao; Hideichi Makino; Yukikazu Kaino; Etsushi Konoue; Jun Ohashi; Kaichi Kida; Yasuhisa Fujii; Ikki Shimizu; Eiji Kawasaki; Masao Fujiyama; Shiori Kondo; Kiyonobu Tanaka; Yoshinao Tarumi; Isamu Seto; Kenichi Kato; Keizo Ohno; Yukiko Kusunoki; Osamu Ebisui; Yasuharu Takada; Katsuya Tanabe; Koji Takemoto; Hiroshi Onuma; Tatsuya Nishimiya; Haruhiko Osawa
Diabetes October 2004, Vol.53, 2684-2690. doi:https://doi.org/10.2337/diabetes.53.10.2684
Brief Genetics Report
Intercellular Adhesion Molecule-1 Concentration Is Genetically Correlated With Insulin Resistance, Obesity, and HDL Concentration in Mexican Americans
Jack W. Kent, Jr; Anthony G. Comuzzie; Michael C. Mahaney; Laura Almasy; David L. Rainwater; John L. VandeBerg; Jean W. MacCluer; John Blangero
Diabetes October 2004, Vol.53, 2691-2695. doi:https://doi.org/10.2337/diabetes.53.10.2691
Melanocortin 4 Receptor Gene Variation Is Associated With Severe Obesity in Pima Indians
Diabetes October 2004, Vol.53, 2696-2699. doi:https://doi.org/10.2337/diabetes.53.10.2696
Genetic Evidence for Discordance Between Obesity- and Diabetes-Related Traits in the LGXSM Recombinant Inbred Mouse Strains
Diabetes October 2004, Vol.53, 2700-2708. doi:https://doi.org/10.2337/diabetes.53.10.2700
Analysis of the Vitamin D Receptor Gene Sequence Variants in Type 1 Diabetes
Sergey Nejentsev; Jason D. Cooper; Lisa Godfrey; Joanna M.M. Howson; Helen Rance; Sarah Nutland; Neil M. Walker; Cristian Guja; Constantin Ionescu-Tirgovişte; David A. Savage; Dag E. Undlien; Kjersti S. Rønningen; Eva Tuomilehto-Wolf; Jaakko Tuomilehto; Kathleen M. Gillespie; Susan M. Ring; David P. Strachan; Barry Widmer; David Dunger; John A. Todd
Diabetes October 2004, Vol.53, 2709-2712. doi:https://doi.org/10.2337/diabetes.53.10.2709
Permanent Neonatal Diabetes due to Mutations in KCNJ11 Encoding Kir6.2: Patient Characteristics and Initial Response to Sulfonylurea Therapy
Jørn V. Sagen; Helge Ræder; Eba Hathout; Naim Shehadeh; Kolbeinn Gudmundsson; Halvor Bævre; Dianne Abuelo; Chanika Phornphutkul; Janne Molnes; Graeme I. Bell; Anna L. Gloyn; Andrew T. Hattersley; Anders Molven; Oddmund Søvik; Pål R. Njølstad
Diabetes October 2004, Vol.53, 2713-2718. doi:https://doi.org/10.2337/diabetes.53.10.2713
Kir6.2 Mutations Are a Common Cause of Permanent Neonatal Diabetes in a Large Cohort of French Patients
Martine Vaxillaire; Céline Populaire; Kanetee Busiah; Hélène Cavé; Anna L. Gloyn; Andrew T. Hattersley; Paul Czernichow; Philippe Froguel; Michel Polak
Diabetes October 2004, Vol.53, 2719-2722. doi:https://doi.org/10.2337/diabetes.53.10.2719
Pharmacology and Therapeutics
Gene Therapy Using Replication-Defective Herpes Simplex Virus Vectors Expressing Nerve Growth Factor in a Rat Model of Diabetic Cystopathy
Katsumi Sasaki; Michael B. Chancellor; William F. Goins; Michael W. Phelan; Joseph C. Glorioso; William C. de Groat; Naoki Yoshimura
Diabetes October 2004, Vol.53, 2723-2730. doi:https://doi.org/10.2337/diabetes.53.10.2723